Prescription Drug Monitoring Programs: Evolution and Evidence | LDI

This Issue Brief reviews the current status and characteristics of prescription drug monitoring programs (PDMPs), their use, and evidence of their effectiveness. It summarizes best practices for PDMPs and the needs for further research and evaluation.

Show Me the Money: Economic Evaluations of Opioid Use Disorder Interventions | LDI

This brief summarizes a new systematic review of economic evaluations of treatments for substance use disorders. The review reveals strong evidence that methadone maintenance therapy is an economically advantageous form of treatment; the economic evidence for buprenorphine and naltrexone treatments is more limited.

A New Option for Management of Neonatal Abstinence Syndrome | New England Journal of Medicine

In the U.S., the use of opioid pain relievers during pregnancy continues to rise. This has contributed to an increased incidence of neonatal abstinence syndrome (NAS), which occurs in approximately 6 per 1000 hospital births and results in long hospital stays and high healthcare costs. While oral morphine is the predominant agent used to treat NAS, in adults, buprenorphine produces less cardiopulmonary depression compared to other long-acting opioids.

Mental healthcare access lacking, despite policies meant to increase rolls of insured | Healthcare Finance News

Despite provisions in the Affordable Care Act meant to reduce insurance coverage disparities for people with mental health issues, access to healthcare services have deteriorated for those reporting severe distress, according to a new study.

Two Versions of Brief Intervention for Drug Use: No Better Than Usual Care In Facilitating Treatment Receipt

This piece summarizes the mounting evidence which suggests that screening, brief intervention, and referral-to-treatment (SBIRT) alone is ineffective in reducing drug use in primary care - but it is unknown whether the referral-to-treatment (RT) component might increase receipt of formal addiction treatment.

Behavioral Health and the Individual Insurance Marketplace

The Thomas Scattergood Behavioral Health Foundation and the Margaret Clark Morgan Foundation believe that now more than ever philanthropic support in the area of policy is critical to improving the health outcomes for all. The two foundations have commissioned a series of six papers that address ways to continue and protect the recent progress of behavioral health policy.

The first in the series is  Behavioral Health and the Individual Health Insurance Market: Preserving Key Elements of Reform by Richard Frank, Ph.D. and Sherry Glied, Ph.D., M.A.

Disruptive Models in Primary Care: Caring for High-Needs, High-Cost Populations

There is a pressing need for new strategies to reinvigorate primary care. HNHC populations are among those most likely to benefit from such reforms. Indeed, without better strategies for managing resource-intensive patients, these time-consuming patients may stymie more general efforts to redesign primary care for the twenty-first century.